Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Fleming

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Objective response rate as a surrogate end point: a commentaryThomas R Fleming
Statistics in Medicine|July 20, 2006
Standard versus adaptive monitoring procedures: A commentaryThomas R Fleming
The New England Journal of Medicine|September 11, 2024
Self-Expanding or Balloon-Expandable TAVR with a Small Aortic AnnulusThomas R Fleming
Clinical Trials (London, England)|February 28, 2015
ResponseThomas R Fleming
Clinical Trials (London, England)|December 6, 2014
Protecting the confidentiality of interim data: addressing current challengesThomas R Fleming
Health Affairs (Project Hope)|January 14, 2005
Surrogate endpoints and FDA's accelerated approval processThomas R Fleming
Annals of Internal Medicine|September 22, 2010
Clinical trials: discerning hype from substanceThomas R Fleming
Annals of Internal Medicine|January 19, 2011
Addressing missing data in clinical trialsThomas R Fleming
The New England Journal of Medicine|September 5, 2008
Identifying and addressing safety signals in clinical trialsThomas R Fleming
Statistics in Medicine|March 7, 2007
Current issues in non-inferiority trialsThomas R Fleming
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Objective response rate as a surrogate end point: a commentaryThomas R Fleming
Statistics in Medicine|July 20, 2006
Standard versus adaptive monitoring procedures: A commentaryThomas R Fleming
The New England Journal of Medicine|September 11, 2024
Self-Expanding or Balloon-Expandable TAVR with a Small Aortic AnnulusThomas R Fleming
Clinical Trials (London, England)|February 28, 2015
ResponseThomas R Fleming
Clinical Trials (London, England)|December 6, 2014
Protecting the confidentiality of interim data: addressing current challengesThomas R Fleming
Health Affairs (Project Hope)|January 14, 2005
Surrogate endpoints and FDA's accelerated approval processThomas R Fleming
Annals of Internal Medicine|September 22, 2010
Clinical trials: discerning hype from substanceThomas R Fleming
Annals of Internal Medicine|January 19, 2011
Addressing missing data in clinical trialsThomas R Fleming
The New England Journal of Medicine|September 5, 2008
Identifying and addressing safety signals in clinical trialsThomas R Fleming
Statistics in Medicine|March 7, 2007
Current issues in non-inferiority trialsThomas R Fleming
Pageof 11